Assessing the feasibility of preoperative preventive vaginal cleansing to prevent contamination of the uterine cavity with vaginal microflora

Dobrokhotova Yu.E., Borovkova E.I., Zaidieva Z.S., Romanovskaya V.V., Nugumanova O.R.

1) Department of Obstetrics and Gynecology, Faculty of General Medicine, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia; 2) Maternity Hospital, a Separate Subdivision, City Clinical Hospital Forty, Moscow City Healthcare Department, Moscow, Russia
Objective: To demonstrate the feasibility of preoperative preventive use of vaginal Elgin tablets with an applicator (VERTEX, Russia) to prevent contamination of the uterine cavity with vaginal microflora during hysteroscopy and separate diagnostic curettage.
Materials and methods: A prospective observational clinical study was conducted in parallel groups involving 50 patients. The investigators formed a study group (n=30) and a control group (n=20), which included patients with vaginal normocenosis and indications for hysteroscopy. The vagina was preoperatively cleansed with Elgin for 6 days in the study group. No preventive treatment was performed in the control group. The study methods included general clinical examinations and real-time polymerase chain reaction (Femoflor-16, DNA-Technology, Moscow).
Resuls: The indications for hysteroscopy and separate diagnostic curettage in the study and control groups were infertility of unknown origin (16.7% and 20%), endometrial polyp (46.7% and 50%), and suspected endometrial disease (36.7% and 30%). After a cycle of preventive therapy with Elgin, the vaginal concentration of lactobacilli vagina did not change, but there was a substantial decrease in opportunistic pathogens (Enterobacteriaceae by 5.7 times, Gardnerella vaginalis by 1.5 times, and Mobiluncus by 1.86 times) (p≤0.001). Staphylococci, streptococci, mycoplasmas, Candida fungi, veillonella, and fusobacteria were completely absent. The intrauterine microbiota in the study group patients was represented only by lactobacilli. The total bacterial mass in the uterine cavity was 1.48 times lower than that in the vagina, while the concentration of lactobacilli was almost 1.5 times lower. A variety of bacteria was identified in the uterine cavity of the control group patients. All the bacteria were characterized by a quantitative decrease as compared to vaginal biocenosis. The titer of streptococci and staphylococci in the uterine cavity was 1.2 times lower than that in the vagina, there were reductions in the titers of gardnerella by 1.7 times, eubacteria by 1.9 times, veillonella by 1.5 times, mobiluncus by 1.4 times, and Candida fungi and ureaplasma by 1.3 times. In the control group, the uterine cavity displayed the representatives of the intestinal microflora and eubacteria in significantly higher titers (the titer was 1.8 times higher), streptococci and staphylococci (that was 2.1 times higher), veillonella and ureaplasma (1.3 times higher), and mobiluncus (1.9 times higher).
Conclusion: A preventive vaginal cleansing cycle before intrauterine manipulations can reduce overall vaginal bacterial contamination and the risk of intrauterine ascending infection from indigenous microflora.

Keywords

vaginal microbiocenosis
intrauterine microflora
chronic endometritis
vaginal cleansing

References

  1. Blaser M.J. The microbiome revolution. J. Clin. Invest. 2014; 124(10): 4162-5. https://dx.doi.org/10.1172/JCI78366.
  2. Thaiss C.A., Zmora N., Levy M., Elinav E. The microbiome and innate immunity. Nature. 2016; 535(7610): 65-74. https://dx.doi.org/10.1038/nature18847.
  3. Abt M.C., Lewis B.B., Caballero S., Xiong H., Carter R.A., Sušac B. et al. Innate immune defenses mediated by two ILC subsets are critical for protection against acute clostridium difficile infection. Cell Host Microbe. 2015; 18: 27-37.https://dx.doi.org/10.1016/j.chom.2015.06.011.
  4. Elliott M.R., Koster K.M., Murphy P.S. Efferocytosis signaling in the regulation of macrophage inflammatory responses. J. Immunol. 2017; 198(4): 1387-94. https://dx.doi.org/10.4049/jimmunol.1601520.
  5. Баев О.Р., Стрижаков А.Н. Резидентная флора генитального тракта и этиология инфекционных осложнений беременности и послеродового периода. Акушерство и гинекология. 1997; 6: 3-7. [Baev O.R., Strizhakov A.N. Resident flora of the genital tract and etiology of infectious complications of pregnancy and the postpartum period. Obstetrics and gynecology. 1997; 6: 3-7. (in Russian)].
  6. Verstraelen H., Vilchez-Vargas R., Desimpel F., Jauregui R., Vankeirsbilck N., Weyers S. et al. Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the v1-2 region of the 16s rRNA gene. PeerJ. 2016; 4: e1602. https://dx.doi.org/10.7717/peerj.1602.
  7. Moreno I., Cicinelli E., Garsia-Grau I., Gonzales-Monfort M., Bau D., Vilella F. et al. The diagnosis of chronic endometritis in infertile asymptomatic women: a comparative study of histology, microbial cultures, hysteroscopy, and molecular microbiology. Am. J. Obstet. Gynecol. 2018; 218(6): 602.e1-602.e16.https://dx.doi.org/10.1016/j.ajog.2018.02.012.
  8. Kyono K., Hashimoto T., Nagai Y., Sakuraba Y. Analysis of endometrial microbiota by 16s ribosomal RNA gene sequencing among infertile patients: a single-center pilot study. Reprod. Med. Biol. 2018; 17(3): 297-306.https://dx.doi.org/10.1002/rmb2.12105.
  9. Cicinelli E., Matteo M., Tinelli R., Lepera A., Alfonso R., Indraccolo U. et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum. Reprod. 2015; 30(2): 323-30. https://dx.doi.org/10.1093/humrep/deu292.
  10. Cicinelli E., Matteo M., Tinelli R., Pinto V., Marinaccio M., Indraccolo U. et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod. Sci. 2014; 21(5): 640-7.https://dx.doi.org/10.1177/1933719113508817.
  11. Кобаидзе Е.Г., Падруль М.М. Некоторые микробиологические характеристики женщин с хроническим эндометритом и его отсутствием. Акушерство, гинекология и репродукция. 2017; 11(4): 14-22. [Kobaidze E.G., Padrul M.M. Microbiological characteristics of the reproductive tract in women with and without chronic endometritis. Obstetrics, Gynecology and Reproduction. 2017; 11(4): 14-22. (in Russian)].https://doi.org/10.17749/2313-7347.2017.11.4.014-022.
  12. Liu Y., Chen X., Huang J., Wang C.C., Yu M.Y., Laird S., Li T.C. Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure. Fertil. Steril. 2018; 109(5): 832-9. https://dx.doi.org/10.1016/j.fertnstert.2018.01.022.
  13. King A.E., Critchley H.O., Kelly R.W. Innate immune defences in the human endometrium. Reprod. Biol. Endocrinol. 2003; 1: 116.https://dx.doi.org/10.1186/1477-7827-1-116.
  14. King A.E., Fleming D.C., Critchley H.O., Kelly R.W. Differential expres-sion of the natural antimicrobials, beta-defensins 3 and 4, in hu¬man endometrium. J. Reprod. Immunol. 2003; 59(1): 1-16. https://dx.doi.org/10.1016/s0165-0378(02)00083-9.
  15. Hooker A.B., Lemmers M., Thurkow A.L., Heymans M.W., Opmeer B.C., Brölmann H.A.M. et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum. Reprod. Update. 2014; 20(2): 262-78. https://dx.doi.org/10.1093/humupd/dmt045.
  16. Кремлева Е.А., Сгибнев А.В., Щетинина Ю.С. Изучение влияния комбинации антимикробных препаратов и преднизолона в форме преднизалона натрия фосфата на микроэкологическое состояние нижних отделов женских половых органов. Акушерство и гинекология. 2019; 11: 209-14. [Kremleva E.A., Sgibnev A.V., Shchetinina Yu.S. Study of the effect of a combination of antimicrobial agents and prednisolone in the form of prednisolone sodium phosphate on the microecological state of the lower female genitalia. Obstetrics and Gynecology. 2019; 11: 209-14. (in Russian)].https://dx.doi.org/10.18565/aig.2019.11.209-214.
  17. Kim T.K., Thomas S.M., Ho M., Sharma S., Reich C.I., Frank J.A. et al. Heterogeneity of vaginal microbial communities within individuals. J. Clin. Microbiol. 2009; 47(4): 1181-9. https://dx.doi.org/10.1128/JCM.00854-08.
  18. Romero R., Espinoza J., Mazor M. Can endometrial infection/in-flammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil. Steril. 2004; 82(4): 799-804. https://dx.doi.org/10.1016/j.fertnstert.2004.05.076.
  19. Петров Ю.А. Роль микробного фактора в генезе хронического эндометрита. Кубанский научный медицинский вестник. 2016; 3: 113-8. [Petrov Yu.A. The role of microbial factor in the genesis of chronic endometritis. Kuban Scientific Medical Bulletin. 2016;(3):113-118. (in Russian)].https://doi.org/10.25207/1608-6228-2016-3-113-118.
  20. Доброхотова Ю.Э., Ганковская Л.В., Боровкова Е.И., Данелян С.Ж., Свитич О.А., Залесская С.А., Меркушова Е.Д., Зайдиева З.С., Скальная В.С., Хасанова Е.М. Колонизационная резистентность и напряженность факторов врожденного иммунитета слизистых влагалища у пациенток с хроническим эндометритом. Вопросы гинекологии, акушерства и перинатологии. 2019; 18(2): 48-56. [Dobrokhotova Yu.E., Gankovskaya L.V., Borovkova E.I., Danelyan S.Zh., Svitich O.A., Zalesskaya S.A., Merkushova E.D., Zaidieva Z.S., Skalnaya V.S., Khasanova E.M. Colonization resistance and intensity of factors of innate immunity of vaginal mucosa in patients with chronic endometritis. uestions of gynecology, obstetrics and perinatology. 2019; 18(2): 48-56.(in Russian)]. https://doi.org/10.20953/1726-1678-2019-2-48-56.
  21. Доброхотова Ю.Э., Ганковская Л.В. Боровкова Е.И. Нугуманова О.Р. Экзогенная цитокинотерапия в лечении пациенток с хроническим эндометритом. Акушерство и гинекология. 2021; 2: 119-26. [Dobrokhotova Yu.E., Gankovskaya L.V., Borovkova E.I., Nugumanova O.R. Exogenous cytokine therapy in the treatment of patients with chronic endometritis. Obstetrics and Gynecology. 2021; 2: 119-26. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.2.119-126.

Received 27.07.2022

Accepted 17.08.2022

About the Authors

Yulia E. Dobrokhotova, Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology of the Faculty of Medicine, N.I. Pirogov RNRMU,
Ministry of Health of Russia, +7(495)722-63-99, pr.dobrohotova@mail.ru, https://orcid.org/0000-0002-7830-2290, 117997, Russia, Moscow, Ostrovityanova str., 1.
Ekaterina I. Borovkova, Dr. Med. Sci., Associate Professor, Professor at the Department of Obstetrics and Gynecology, N.I. Pirogov RNRMU, Ministry of Health of Russia, +7(495)722-63-99, Katyanikitina@mail.ru, https://orcid.org/0000-0001-7140-262X, 117997, Russia, Moscow, Ostrovityanova str., 1.
Valentina V. Romanovskaya, PhD, Teaching Assistant at the Department of Obstetrics and Gynecology, N.I. Pirogov RNRMU, Ministry of Health of Russia,
+7(495)722-63-99, valentinaromano2005@yandex.ru, https://orcid.org/0000-0003-0413-5431, 117997, Russia, Moscow, Ostrovityanova str., 1.
Zulya S. Zaidieva, PhD, Head of the Consultative and Diagnostic Department, Maternity Hospital at Moscow City Clinical Hospital No. 40,
+7(903)788-39-95, dr.zaydieva@mail.ru, 129301, Russia, Moscow, Taimyrskaya str., 6.

Authors’ contributions: Dobrokhotova Yu.E. – development of the design of the investigation, writing the article; Borovkova E.I., Zaidieva Z.S., Romanovskaya V.V. – material collection, writing the article; Nugumanova O.R. – material collection, statistical analysis.
Conflicts of interest: The authors declare that there are no possible conflicts of interest.
Funding: The investigation has been sponsored by Vertex Co.
Ethical Approval: The study was reviewed and approved by the Ethics Committee of the N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia.
Patient Consent for Publication: All patients provided informed consent for the publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Dobrokhotova Yu.E., Borovkova E.I., Zaidieva Z.S., Romanovskaya V.V., Nugumanova O.R. Assessing the feasibility of preoperative preventive vaginal cleansing to prevent contamination of the uterine cavity with vaginal microflora.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2022; 8: 132-142 (in Russian)
https://dx.doi.org/10.18565/aig.2022.8.132-142

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.